The Parkinsons Disease Drugs Market size was valued at US$ 8.37 billion in 2025 and is projected to reach US$ 16.62 billion by 2033, growing at a CAGR of 8.95% during 2026–2033.
Senior management should treat the market as a portfolio-allocation problem. The relevant question is where product, channel, and service resources can create a defendable position rather than simply...
